LED Therapy for Third Molar Surgery

Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age20-55
SponsorHuashan Hospital

About this trial

LED Therapy for third molar surgery

Eligibility criteria

Qualifiers

Healthy Asians;

20-55 years old;

Having mandibular third molars that are inappropriately erupted and need to be extracted due to caries, orthodontic reasons and/or periodontal disease;

Disqualifiers

Underlying diseases: diabetes, cardiovascular disease, coagulation disorder, osteoporosis, hypertension, neurological disease, psychological disorder, tumor, systemic infection or cyst at the extraction site;

Women who are preparing for pregnancy, pregnant or breastfeeding;

Medication history: use of analgesics, anti-inflammatory drugs and/or antibacterial drugs 2 weeks before tooth extraction, need for systemic medication other than acetaminophen after surgery, allergy to acetaminophen, use of anticoagulants, bisphosphonates;

Bad habits, such as addicted to smoking, drinking, etc.;

Trial design

Treatments tested in this trial

  • photobiomodulation
  • Antibiotic

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators